Biotechnologies Assets SA (BST.MC)

EUR 0.3

(2.54%)

Gross Profit Summary of Biotechnologies Assets SA

Biotechnologies Assets SA's latest annual gross profit in 2023 was 3.45 Million EUR , up 32.64% from previous year.
Biotechnologies Assets SA's latest quarterly gross profit in 2023 FY was 3.49 Million EUR , up 32.64% from previous quarter.
Biotechnologies Assets SA reported a annual gross profit of 2.63 Million EUR in annual gross profit 2022, down -13.21% from previous year.
Biotechnologies Assets SA reported a annual gross profit of 3.03 Million EUR in annual gross profit 2021, up 11.55% from previous year.
Biotechnologies Assets SA reported a quarterly gross profit of 735.64 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.
Biotechnologies Assets SA reported a quarterly gross profit of 993.27 Thousand EUR for 2023 Q3, up 35.02% from previous quarter.

Annual Gross Profit Chart of Biotechnologies Assets SA (2023 - 2010)

Historical Annual Gross Profit of Biotechnologies Assets SA (2023 - 2010)

Year	Gross Profit	Gross Profit Growth
2023	3.45 Million EUR	32.64%
2022	2.63 Million EUR	-13.21%
2021	3.03 Million EUR	11.55%
2020	2.72 Million EUR	-89.54%
2019	26 Million EUR	77.95%
2018	14.61 Million EUR	345.73%
2017	3.27 Million EUR	31.82%
2016	2.48 Million EUR	43.18%
2015	1.73 Million EUR	-33.6%
2014	2.61 Million EUR	98.16%
2013	1.32 Million EUR	41.6%
2012	932.42 Thousand EUR	18.2%
2011	788.83 Thousand EUR	97.9%
2010	398.59 Thousand EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2023 FY	3.49 Million EUR	32.64%
2023 Q2	735.64 Thousand EUR	0.0%
2023 Q3	993.27 Thousand EUR	35.02%
2023 Q1	735.64 Thousand EUR	-11.15%
2023 Q4	993.27 Thousand EUR	0.0%
2022 FY	2.63 Million EUR	-13.21%
2022 Q4	827.99 Thousand EUR	0.0%
2021 FY	3.03 Million EUR	11.55%
2020 FY	2.72 Million EUR	-89.54%
2019 FY	26 Million EUR	77.95%
2018 FY	14.61 Million EUR	345.73%
2017 FY	3.27 Million EUR	31.82%
2016 FY	2.48 Million EUR	43.18%
2015 FY	1.73 Million EUR	-33.6%
2014 FY	2.61 Million EUR	98.16%
2013 FY	1.32 Million EUR	41.6%
2012 FY	932.42 Thousand EUR	18.2%
2011 FY	788.83 Thousand EUR	97.9%
2010 FY	398.59 Thousand EUR	0.0%

Peer Gross Profit Comparison of Biotechnologies Assets SA

Name	Gross Profit	Gross Profit Difference
Atrys Health, S.A.	52.61 Million EUR	93.428%
Pharma Mar, S.A.	148.54 Million EUR	97.672%
Laboratorios Farmaceuticos Rovi, S.A.	492.28 Million EUR	99.298%